Yamamoto, Akira

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

Nakamura, H., Arakawa, K., Itakura, H., Kitabatake, A., Goto, Y., Toyota, T., Nakaya, N., Nishimoto, S., Muranaka, M., Yamamoto, A., et al. (2006) · The Lancet

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 941

Serum Lipid Survey and Its Recent Trend in the General Japanese Population in 2000

Arai, H., Yamamoto, A., Matsuzawa, Y., Saito, Y., Yamada, N., Oikawa, S., Mabuchi, H., Teramoto, T., Sasaki, J., Nakaya, N., et al. (2005) · Journal of Atherosclerosis and Thrombosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 94

New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.

Yamamura, T., Yamamoto, A., Sumiyoshi, T., Hiramori, K., Nishioeda, Y., & Nambu, S. (1984) · Journal of Clinical Investigation

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 91

Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia

Harada-Shiba, M., Sugisawa, T., Makino, H., Abe, M., Tsushima, M., Yoshimasa, Y., Yamashita, T., Miyamoto, Y., Yamamoto, A., Tomoike, H., et al. (2010) · Journal of Atherosclerosis and Thrombosis

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 70

A new isoform of apolipoprotein E — Apo E-5 — Associated with hyperlipidemia and atherosclerosis

Yamamura, T., Yamamoto, A., Hiramori, K., & Nambu, S. (1984) · Atherosclerosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 70

Analysis of Apolipoprotein E7 (Apolipoprotein E-Suita) Gene from a Patient with Hyperlipoproteinemia1

Tajima, S., Yamamura, T., Menju, M., & Yamamoto, A. (1989) · The Journal of Biochemistry

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 44

Analysis of Apolipoprotein E5 Gene from a Patient with Hyperlipoproteinemia1

Tajima, S., Yamamura, T., & Yamamoto, A. (1988) · The Journal of Biochemistry

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 42

Characterization of apolipoprotein E7 (Glu244→Lys, Glu245→Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis

Yamamura, T., Dong, L.-M., & Yamamoto, A. (1999) · Journal of Lipid Research

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 25

Enhanced binding activity of an apolipoprotein E mutant, apo E5, to LDL receptors on human fibroblasts

Dong, L.-M., Yamamura, T., & Yamamoto, A. (1990) · Biochemical and Biophysical Research Communications

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 23

Site-directed mutagenesis of an apolipoprotein E mutant, apo E5(Glu3→Lys) and its binding to low density lipoprotein receptors

Dong, L.-M., Yamamura, T., Tajima, S., & Yamamoto, A. (1992) · Biochemical and Biophysical Research Communications

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 8